These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
25. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
26. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468 [TBL] [Abstract][Full Text] [Related]
27. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Kawabata S; Higgins GA; Gordon JW Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460 [TBL] [Abstract][Full Text] [Related]
28. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models]. Brion JP Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876 [TBL] [Abstract][Full Text] [Related]
29. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease. Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696 [TBL] [Abstract][Full Text] [Related]
30. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Howlett DR; Richardson JC; Austin A; Parsons AA; Bate ST; Davies DC; Gonzalez MI Brain Res; 2004 Aug; 1017(1-2):130-6. PubMed ID: 15261108 [TBL] [Abstract][Full Text] [Related]
31. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
32. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains. Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313 [TBL] [Abstract][Full Text] [Related]
33. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition. Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619 [TBL] [Abstract][Full Text] [Related]
34. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007 [TBL] [Abstract][Full Text] [Related]
35. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967 [TBL] [Abstract][Full Text] [Related]
36. Metallothionein-I and -III expression in animal models of Alzheimer disease. Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170 [TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels. Köhler C; Ebert U; Baumann K; Schröder H Neurobiol Dis; 2005 Nov; 20(2):528-40. PubMed ID: 15921918 [TBL] [Abstract][Full Text] [Related]
38. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology. van Groen T; Kadish I Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676 [TBL] [Abstract][Full Text] [Related]
39. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014 [TBL] [Abstract][Full Text] [Related]